BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25239411)

  • 1. CD8+ lymphocyte intratumoral infiltration as a stage-independent predictor of Merkel cell carcinoma survival: a population-based study.
    Paulson KG; Iyer JG; Simonson WT; Blom A; Thibodeau RM; Schmidt M; Pietromonaco S; Sokil M; Warton EM; Asgari MM; Nghiem P
    Am J Clin Pathol; 2014 Oct; 142(4):452-8. PubMed ID: 25239411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.
    Paulson KG; Iyer JG; Tegeder AR; Thibodeau R; Schelter J; Koba S; Schrama D; Simonson WT; Lemos BD; Byrd DR; Koelle DM; Galloway DA; Leonard JH; Madeleine MM; Argenyi ZB; Disis ML; Becker JC; Cleary MA; Nghiem P
    J Clin Oncol; 2011 Apr; 29(12):1539-46. PubMed ID: 21422430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Role of Tumoral PD-L1 and IDO1 Expression, and Intratumoral CD8+ and FoxP3+ Lymphocyte Infiltrates in 132 Primary Cutaneous Merkel Cell Carcinomas.
    Donizy P; Wu CL; Kopczynski J; Pieniazek M; Biecek P; Ryś J; Hoang MP
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Merkel cell carcinomas infiltrated with CD33
    Kervarrec T; Gaboriaud P; Berthon P; Zaragoza J; Schrama D; Houben R; Le Corre Y; Hainaut-Wierzbicka E; Aubin F; Bens G; Domenech J; Guyétant S; Touzé A; Samimi M
    J Am Acad Dermatol; 2018 May; 78(5):973-982.e8. PubMed ID: 29273486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic biopsy does not commonly induce intratumoral CD8 T cell infiltration in Merkel cell carcinoma.
    Koba S; Paulson KG; Nagase K; Tegeder A; Thibodeau R; Iyer JG; Narisawa Y; Nghiem P
    PLoS One; 2012; 7(7):e41465. PubMed ID: 22859987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ transplant recipients with Merkel cell carcinoma have reduced progression-free, overall, and disease-specific survival independent of stage at presentation.
    Arron ST; Canavan T; Yu SS
    J Am Acad Dermatol; 2014 Oct; 71(4):684-90. PubMed ID: 24993599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study.
    Sihto H; Böhling T; Kavola H; Koljonen V; Salmi M; Jalkanen S; Joensuu H
    Clin Cancer Res; 2012 May; 18(10):2872-81. PubMed ID: 22467679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute lymphocyte count: a potential prognostic factor for Merkel cell carcinoma.
    Johnson ME; Zhu F; Li T; Wu H; Galloway TJ; Farma JM; Perlis CS; Turaka A
    J Am Acad Dermatol; 2014 Jun; 70(6):1028-35. PubMed ID: 24666998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular E-selectin expression correlates with CD8 lymphocyte infiltration and improved outcome in Merkel cell carcinoma.
    Afanasiev OK; Nagase K; Simonson W; Vandeven N; Blom A; Koelle DM; Clark R; Nghiem P
    J Invest Dermatol; 2013 Aug; 133(8):2065-73. PubMed ID: 23353989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data.
    Smith VA; Camp ER; Lentsch EJ
    Laryngoscope; 2012 Jun; 122(6):1283-90. PubMed ID: 22522673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-Infiltrating Merkel Cell Polyomavirus-Specific T Cells Are Diverse and Associated with Improved Patient Survival.
    Miller NJ; Church CD; Dong L; Crispin D; Fitzgibbon MP; Lachance K; Jing L; Shinohara M; Gavvovidis I; Willimsky G; McIntosh M; Blankenstein T; Koelle DM; Nghiem P
    Cancer Immunol Res; 2017 Feb; 5(2):137-147. PubMed ID: 28093446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Impact of MCPyV and TIL Subtyping in Merkel Cell Carcinoma: Evidence from a Large European Cohort of 95 Patients.
    Ricci C; Righi A; Ambrosi F; Gibertoni D; Maletta F; Uccella S; Sessa F; Asioli S; Pellilli M; Maragliano R; La Rosa S; Papotti MG; Asioli S
    Endocr Pathol; 2020 Mar; 31(1):21-32. PubMed ID: 31808008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma.
    Smith VA; MaDan OP; Lentsch EJ
    Otolaryngol Head Neck Surg; 2012 Mar; 146(3):403-8. PubMed ID: 22166964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of surgery on survival of patients aged 75 years or older with Merkel cell carcinoma.
    Ren K; Yin X; Zhou B
    Cancer Med; 2022 Jan; 11(1):128-138. PubMed ID: 34821054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p63 expression in Merkel cell carcinoma predicts poorer survival yet may have limited clinical utility.
    Stetsenko GY; Malekirad J; Paulson KG; Iyer JG; Thibodeau RM; Nagase K; Schmidt M; Storer BE; Argenyi ZB; Nghiem P
    Am J Clin Pathol; 2013 Dec; 140(6):838-44. PubMed ID: 24225752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage.
    Paulson KG; Iyer JG; Blom A; Warton EM; Sokil M; Yelistratova L; Schuman L; Nagase K; Bhatia S; Asgari MM; Nghiem P
    J Invest Dermatol; 2013 Mar; 133(3):642-646. PubMed ID: 23190897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high neutrophil-to-lymphocyte ratio as a potential marker of mortality in patients with Merkel cell carcinoma: A retrospective study.
    Zaragoza J; Kervarrec T; Touzé A; Avenel-Audran M; Beneton N; Esteve E; Wierzbicka Hainaut E; Aubin F; Machet L; Samimi M
    J Am Acad Dermatol; 2016 Oct; 75(4):712-721.e1. PubMed ID: 27544490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of a circulating tumor cell assay in Merkel cell carcinoma.
    Blom A; Bhatia S; Pietromonaco S; Koehler K; Iyer JG; Nagase K; Paulson K; Sabath DE; Nghiem P
    J Am Acad Dermatol; 2014 Mar; 70(3):449-55. PubMed ID: 24388423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved survival in women versus men with merkel cell carcinoma.
    Tam M; Luu M; Barker CA; Gharavi NM; Hamid O; Shiao SL; Nguyen AT; Lu DJ; Ho AS; Zumsteg ZS
    J Am Acad Dermatol; 2021 Feb; 84(2):321-329. PubMed ID: 32423829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel node status and immunosuppression: recurrence factors in localized Merkel cell carcinoma.
    Jouary T; Kubica E; Dalle S; Pages C; Duval-Modeste AB; Guillot B; Mansard S; Saiag P; Aubin F; Bedane C; Dalac S; Dompmartin A; Granel-Brocard F; Lok C; Stoebner PE; Lacour JP; Leccia MT; Diallo A; Ezzedine K; Mateus C
    Acta Derm Venereol; 2015 Sep; 95(7):835-40. PubMed ID: 25784178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.